CME Group Inc. (NASDAQ:CME) Shares Bought by Meiji Yasuda Asset Management Co Ltd.

Meiji Yasuda Asset Management Co Ltd. lifted its position in shares of CME Group Inc. (NASDAQ:CME) by 6.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,222 shares of the financial services provider’s stock after acquiring an additional 927 shares during the quarter. Meiji Yasuda Asset Management Co Ltd.’s holdings in CME Group were worth $2,993,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Meiji Yasuda Life Insurance Co raised its stake in shares of CME Group by 9.2% during the 2nd quarter. Meiji Yasuda Life Insurance Co now owns 11,764 shares of the financial services provider’s stock worth $2,313,000 after buying an additional 993 shares in the last quarter. Clearstead Trust LLC boosted its stake in shares of CME Group by 27.0% in the second quarter. Clearstead Trust LLC now owns 3,066 shares of the financial services provider’s stock valued at $603,000 after buying an additional 652 shares in the last quarter. Moors & Cabot Inc. grew its holdings in CME Group by 10.0% during the second quarter. Moors & Cabot Inc. now owns 31,452 shares of the financial services provider’s stock worth $6,183,000 after acquiring an additional 2,853 shares during the period. Citizens Financial Group Inc. RI raised its position in CME Group by 16.0% in the second quarter. Citizens Financial Group Inc. RI now owns 1,251 shares of the financial services provider’s stock worth $246,000 after acquiring an additional 173 shares in the last quarter. Finally, Mesirow Financial Investment Management Inc. lifted its holdings in CME Group by 5.6% in the second quarter. Mesirow Financial Investment Management Inc. now owns 12,633 shares of the financial services provider’s stock valued at $2,491,000 after acquiring an additional 672 shares during the period. 87.75% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the stock. JPMorgan Chase & Co. increased their price target on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft increased their target price on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a report on Thursday, August 15th. Keefe, Bruyette & Woods boosted their price target on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research note on Thursday, July 25th. Bank of America downgraded CME Group from a “neutral” rating to an “underperform” rating and dropped their price objective for the company from $212.00 to $177.00 in a research note on Tuesday, September 3rd. Finally, Piper Sandler reiterated an “overweight” rating and set a $225.00 target price on shares of CME Group in a research report on Tuesday, August 20th. Four research analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $209.73.

Insider Buying and Selling

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The disclosure for this sale can be found here. 0.30% of the stock is owned by company insiders.

CME Group Stock Performance

CME Group stock opened at $216.30 on Thursday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $223.80. The stock has a fifty day moving average of $207.08 and a two-hundred day moving average of $207.54. The company has a market capitalization of $77.88 billion, a price-to-earnings ratio of 24.61, a PEG ratio of 8.85 and a beta of 0.55.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. The firm had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm’s quarterly revenue was up 12.7% compared to the same quarter last year. During the same quarter last year, the business posted $2.30 EPS. On average, analysts anticipate that CME Group Inc. will post 9.94 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be paid a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.13%. The ex-dividend date is Monday, September 9th. CME Group’s payout ratio is 52.33%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.